Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Cash from Investing Activities (2024)

Opus Genetics (IRD) has disclosed Cash from Investing Activities for 5 consecutive years, with $28829.0 as the latest value for Q1 2014.

  • On a quarterly basis, Cash from Investing Activities fell 78.49% to $28829.0 in Q1 2014 year-over-year; TTM through Sep 2021 was $28829.0, a N/A change, with the full-year FY2024 number at $1.2 million, changed N/A from a year prior.
  • Cash from Investing Activities was $28829.0 for Q1 2014 at Opus Genetics, up from -$1.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.5 million in Q4 2011 to a low of -$3.0 million in Q1 2011.
  • A 5-year average of -$540059.7 and a median of -$395807.0 in 2010 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 240.59% in 2011, then plummeted 648.52% in 2012.
  • Opus Genetics' Cash from Investing Activities stood at -$1.1 million in 2010, then surged by 240.59% to $1.5 million in 2011, then plummeted by 158.15% to -$874628.0 in 2012, then crashed by 46.44% to -$1.3 million in 2013, then soared by 102.25% to $28829.0 in 2014.
  • Per Business Quant, the three most recent readings for IRD's Cash from Investing Activities are $28829.0 (Q1 2014), -$1.3 million (Q4 2013), and -$1.6 million (Q3 2013).